BioLineRx Ltd. ( BLRX) - Stock Earnings
BLRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.4 million USD | 195211 USD |
| 2026Q1 | -2.6 million USD | 477000 USD |
| 2026Q2 | -3.1 million USD | 299048 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BLRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -60.6 million USD | 4.8 million USD |
| 2024 | -9.2 million USD | 28.9 million USD |
| 2025 | -1.2 million USD | 1.2 million USD |
| 2026 Est. | — | — |
BLRX
Price: $2.08
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 323100
Ebitda: -7.1 millionMarket Capitalization: 10.3 million